How IITs and IISc are redefining medical education in India

In March 2026, IIT Kharagpur—the oldest Indian Institute of Technology (IIT) that has been training thousands of minds to design bridges, cars, and computer chips for the last 75 years did something unprecedented. It formally applied to the National Medical Commission (NMC) to offer a postgraduate medical degree, the Doctor of Medicine (MD).

It was not an isolated move. In August 2026, an alumnus of IIT-Kanpur pledged a massive ₹400 crore boost —building on a landmark ₹100 crore donation in 2022 — to expand its medical school and 450-bed super-specialty hospital to offer postgraduate programs in super-specialty medicine.

Within days, IIT-Madras stepped up to announce an even bolder vision: offering not just an MD, but an MBBS and a Ph.D. in medicine through its School of Medical Sciences, started in 2023.

A century-old assumption — that engineering colleges build engineers and medical colleges make doctors — is falling apart.

For over six decades, the Indian Institutes of Technology (IITs) have served as India’s temples of engineering excellence. So why are they suddenly stepping into healthcare and running hospitals?

The short answer is: modern healthcare is no longer just about stethoscopes and prescriptions. It is driven by algorithms, microfluidics, robotic surgery, and biocompatible materials. Walk into a high-tech operating theatre today, and you will find as much engineering as medicine: robotic arms, real-time imaging, AI-assisted diagnostics, and 3D-printed implants.

Medicine is not the only sector witnessing this shift. Nursing and allied health are also transitioning. IIT Guwahati’s School of Health Sciences and Technology already trains students jointly with AIIMS Guwahati and the National Institute of Pharmaceutical Education and Research (NIPER). Meanwhile, IIT Kharagpur’s hospital project includes explicit plans for a nursing college and a paramedical training school alongside its medical courses.

India’s premier technology institutes have realised that the major challenges of this century — climate change, cancer, cognition, and clean energy — cannot be solved from inside a single-discipline silo. Engineering schools that just focus on engineering risk becoming mere component suppliers to the institutions that have a massive impact on solving these problems.

While the IITs made headlines with plans for traditional medical degrees, the Indian Institute of Science (IISc), Bengaluru, has pursued a distinctly different, research-first pathway into medical education.

Now established as the Tata IISc Medical School following a partnership with the Tata Group, the campus is executing an ambitious clinical and research infrastructure rollout.

The foundation stone for the 832-bed non-profit multi-specialty hospital — supported by a landmark ₹425 crore donation — was laid by the Prime Minister way back in June 2022 and was originally scheduled to be functional by December 2024. Now it is slated to become fully operational by late 2026 and admit the first batch of students in its flagship integrated dual-degree MD-Ph.D. program in July 2027.

What sets IISc apart from traditional medical colleges — and even peer technical institutes — is its structural integration with the global and domestic pharmaceutical and biotechnology industries. Instead of treating industry interactions as post hoc research grants, IISc embeds pharmaceutical co-innovation directly into its medical school ecosystem.

Specialised research hubs on campus — such as the Cipla Foundation Centre for Pulmonary Medicine — are integrated into the curriculum to deliver advanced respiratory care, targeted clinical trials, and drug development training alongside specialised units like the Centre for Brain Research (CBR).

Hidden beneath the admissions headlines is an even bigger opportunity. Cross-disciplinary campuses are where medical devices, diagnostics, and therapeutics actually get invented.

This is because the clinicians who understand the patient’s pain points and the engineers who can build the solutions are finally standing in the same hallway.

For a country that imports the vast majority of its high-end medical devices, the economic and social benefits of getting this right are immense: indigenous implants, affordable diagnostics, and AI tools designed for Indian disease burdens and price points. This vision aligns with the National Education Policy (NEP) 2020, which actively pushes higher education institutions to break down rigid disciplinary walls and evolve into Multidisciplinary Education and Research Universities (MERUs).

Top-tier medical institutions like AIIMS, CMC Vellore, and JIPMER built their reputations on a time-tested formula: elite NEET-UG entry, massive patient volumes, and clinical research deeply embedded in bedside patient care.

What the IITs and IISc are betting on is a completely different edge: training doctors and physician-scientists who are fluent in engineering and computational tools—like signal processing, AI/ML, medical robotics, genetics, and device design—from day one, inside the very institute building those tools.